Cocrystal Pharma announces the appointment of Fred Hassan to its Board of Directors, increasing its Board membership to six. Mr. Hassan’s distinguished 40-year career includes serving in senior executive and director positions at global pharmaceutical companies and leading investment firms. Earlier this month, Cocrystal announced Mr. Hassan’s $2 million investment in the Company through an at-the-market private placement.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on COCP:
- Biotech Alert: Searches spiking for these stocks today
- Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
- Cocrystal Pharma reports FY22 ($4.77), consensus ($4.10)
- Cocrystal Pharma to Highlights Progress with Its Antiviral Portfolio at the Virtual Investor Summit on March 29, 2023
